| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |